Actively Recruiting

Age: 18Years +
All Genders
NCT06979700

Early WAKE-up Predictors After Out-of-Hospital Cardiac Arrest

Led by University of Aarhus · Updated on 2025-11-18

250

Participants Needed

2

Research Sites

133 weeks

Total Duration

On this page

Sponsors

U

University of Aarhus

Lead Sponsor

A

Aarhus University Hospital

Collaborating Sponsor

AI-Summary

What this Trial Is About

WAKE-OHCA is a prospective observational substudy of the Danish Out-of-Hospital Cardiac Arrest (DANOHCA) trial, identifier NCT05895838. The aim is to collect early neuromonitoring data to identify key predictors of successful wake-up.

CONDITIONS

Official Title

Early WAKE-up Predictors After Out-of-Hospital Cardiac Arrest

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Age 18 years or older
  • Out-of-hospital cardiac arrest of presumed cardiac cause
  • Sustained return of spontaneous circulation for more than 20 minutes
  • Unconsciousness (Glasgow Coma Scale less than 9) after sustained return of spontaneous circulation at randomization
Not Eligible

You will not qualify if you...

  • Suspected pregnancy in females of childbearing potential without a negative pregnancy test
  • Known bleeding disorders (except medically induced coagulopathy)
  • Suspected or confirmed acute intracranial bleeding
  • Suspected or confirmed acute stroke
  • Unwitnessed asystole
  • Known limitations in therapy or Do Not Resuscitate order
  • Diseases making survival beyond 180 days unlikely
  • Pre-arrest functional status of CPC 3 or 4
  • More than 3 hours from return of spontaneous circulation to screening
  • Systolic blood pressure below 80 mm Hg despite treatment (unless recovering)
  • Use of intra-aortic balloon pump, axial flow device, or ECMO (unless removed during inclusion window)
  • Body temperature below 30°C on admission
  • Known allergy to dexamethasone or olanzapine
  • Ongoing treatment with olanzapine or dexamethasone within 48 hours
  • Known back or hip conditions preventing positioning with backrest from 0 to 45 degrees
  • Known or suspected Long QT Syndrome
  • Active fungal disease (localized skin lesions allowed)
  • Estimated body weight less than 45 kg

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 2 locations

1

Department of Intensive Care Medicine

Aarhus N, Denmark, DK-8200

Actively Recruiting

2

Department of Cardiology, The Heart Centre, Rigshospitalet

Copenhagen, Denmark, DK-2100

Actively Recruiting

Loading map...

Research Team

C

Christopher Torp Lohse, MD

CONTACT

A

Anders Grejs, MD, PhD

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

0

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here